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Abstract Chronic otitis media (OM) is common in Down
syndrome (DS), but underlying aetiology is unclear. We
analysed the entire available mouse resource of partial
trisomy models of DS looking for histological evidence of
chronic middle-ear inflammation. We found a highly
penetrant OM in the Dp(16)1Yey mouse, which carries a
complete trisomy of MMU16. No OM was found in the
Dp(17)1Yey mouse or the Dp(10)1Yey mouse, suggesting
disease loci are located only on MMU16. The Ts1Cje,
Ts1RhR, Ts2Yah, and Ts65Dn trisomies and the transc-
homosomic Tc1 mouse did not develop OM. On the basis
of these findings, we propose a two-locus model for
chronic middle-ear inflammation in DS, based upon
epistasis of the regions of HSA21 not in trisomy in the Tc1
mouse. We also conclude that environmental factors likely
play an important role in disease onset.
Introduction
Down syndrome (DS) is the most common human chro-
mosomal abnormality, occurring in 1/750 live births, and is
due to partial or total trisomy HSA21. Variable clinical
features include skull and midface malformation, cardiac
anomalies, hypotonia, delayed growth, developmental
disorders, thyroid disease, obesity, and also chronic otitis
media (OM). Most children with DS develop OM with
effusion (OME), which is often chronic (COME) and leads
to a hearing loss that can compound learning difficulties
(Libb et al. 1985; Marcell and Cohen 1992). A longitudinal
study of 79 children with DS reported that OME was
diagnosed in 93 % at age one, falling to 68 % by age 5
(Barr et al. 2011). Similar findings have been reported in
other series (Brooks et al. 1972; Balkany et al. 1979;
Maurizi et al. 1985; Dahle and McCollister 1986; Hass-
mann et al. 1998; Kattan et al. 2000; Mitchell et al. 2003;
Park et al. 2011). COME may persist, and at least 10–20 %
of adults with DS have a conductive hearing loss (Evenhuis
et al. 1992; Van Buggenhout et al. 1999). Middle-ear
inflammation may also be subclinical (Roizen et al. 1994).
Several authorities advise routine and regular audiological
screening of children with DS (American Academy of
Pediatrics 2001; Downs Syndrome Medical Interest Group
2004).
Standard treatments for COME are not as effective in
children with DS. Grommets (ventilation tubes) in this
population may not significantly improve hearing, have
little if any effect on disease recurrence, and are not
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infrequently complicated by infection (Selikowitz 1993;
Iino et al. 1999; Shott et al. 2001). Some advocate hearing
aids as the preferred treatment for COME in DS (National
Institute for Health and Clinical Excellence 2008). An
understanding of the pathogenic mechanisms leading to
chronic middle-ear inflammation in DS offers potential for
targeted and more effective therapy of COME in this
population. It may also provide insights into mechanisms
of inflammation in nonsyndromic COME, which is also
highly heritable (Casselbrant et al. 1999). Specifically,
trisomy in DS could mimic hypermorphic polymorphisms
underlying nonsyndromic disease.
The aetiology of chronic middle-ear inflammation in
DS is not understood. Children with DS are more prone
to infection as a result of defective mucosal immunology
(Kusters et al. 2009). This could explain the onset of
OM, but the persistent nonsuppurative inflammation seen
in COME is not thought to reflect persistent bacterial
infection. Several authorities suggest that an anatomical
anomaly of the Eustachian tube in DS contributes to
nonresolving disease (Bluestone et al. 2005), but the only
published study on Eustachian tube patency in DS did
not demonstrate the tube to be obstructed (White et al.
1984).
DS is presumed to arise as a consequence of either an
extra copy of protein-coding sequences that are dosage-
sensitive or an extra copy of non-protein-coding sequen-
ces that are regulatory or otherwise functional (Anton-
arakis et al. 2004; Gardiner and Costa 2006; Megarbane
et al. 2009; Tan et al. 2009; Wiseman et al. 2009).
HSA21 is the smallest human autosome, with only around
300 genes, and so perhaps only a handful of genes play a
role in the phenotypic manifestations of DS. Individuals
with partial trisomy of HSA21 offer serendipitous clues to
identify critical regions for DS phenotypes. Initial analy-
ses of such individuals suggested that all or most phe-
notypic manifestations of DS were due to a short critical
region (McCormick et al. 1989; Rahmani et al. 1989), but
more recent analysis refutes this and suggests that loci
determining the DS phenotype are scattered across
HSA21 (Lyle et al. 2004; Korbel et al. 2009). This ana-
lysis had not been undertaken specifically for the OM
phenotype, but given the rarity of partial trisomy HSA21
and the lack of a large database of genotype-phenotype
correlation for aneuploidies, such analysis is difficult at
present.
Readouts of the transcriptome of HSA21 have also been
used to define critical genes. Data from human (Ait Yahya-
Graison et al. 2007) and mouse (Lyle et al. 2004) show that
only around a third of the genes on HSA21 are transcribed
at more than the theoretical 1.5-fold increase, suggesting
that the majority of trisomic loci are compensated for by
negative feedback that modulates transcriptional activity or
mRNA stability. Although this does appear to narrow the
possibilities, the method is not entirely reliable. Data of the
transcriptome from mouse and human differ, as do data
from different tissue types (Lyle et al. 2004). In addition,
transcription is but one component of gene expression
(Schwanhausser et al. 2011), so small changes in tran-
scription could have a large phenotypic effect at some loci,
and large changes in transcription could have little or no
phenotypic effect at other loci.
There has been increasing interest in using mouse
models to unravel pathobiology in DS. The syntenic
regions to HSA21 are scattered across the mouse genome
on MMU16, MMU17, and MMU10 (see Fig. 1a), which
makes genetic modelling difficult (Gardiner et al. 2003).
However, there is a growing library of mouse models of
DS. The Ts65Dn mouse (Davisson et al. 1993), Ts1Cje
mouse (Sago et al. 1998), Ts2Yah mouse (Herault et al.
2009), Ts1Rhr mouse (Olson et al. 2004), Dp(16)1Yey
mouse (Li et al. 2007), Dp(10)1Yey mouse (Yu et al.
2010), and Dp(17)1Yey mouse (Yu et al. 2010) each carry
a partial trisomy for the homologous genes of HSA21.
Together these models cover almost all regions triplicated
in DS (Fig. 1b). In addition, the Tc1 mouse is a trans-
chromosomic model, carrying most of HSA21 in addition
to the full complement of mouse chromosomes (O’Doherty
et al. 2005).
This mouse library has been surveyed to identify loci
responsible for some of the phenotypic manifestations of
DS, but it has never been systematically interrogated for
the presence of OM. The Ts65Dn mouse, which carries a
15.6-Mb segmental trisomy of MMU16 (Duchon et al.
2011; Reinholdt et al. 2011), has been reported to develop
spontaneous chronic OM (Han et al. 2009), and recently
the Tc1 mouse has been reported to not develop chronic
OM (Kuhn et al. 2012). There are no reports of the pre-
sence or absence of OM in the other murine models of DS.
In this study we systematically screened the murine
resource of DS models to identify the histological presence
of chronic OM, with the aim of narrowing and defining a
critical region or set of loci underlying this phenotype.
Materials and methods
Mouse strains
We analysed cadaveric specimens of almost the entire
reported library of DS mouse models. Specimens of the
Ts65Dn mouse, the Ts1Cje mouse, the Ts2Yah mouse, and
the Ts1Rhr mouse were obtained from the Institut Clinique
de la Souris, Strasbourg. Specimens of the Dp(16)1Yey
440 M. F. Bhutta et al.: Surveying Down syndrome mouse library for otitis media
123
mouse, the Dp(10)1Yey mouse, and the Dp(17)1Yey
mouse were obtained from Roswell Park, NY, USA.
Specimens of the Tc1 mouse and additional specimens of
the Ts65Dn mouse were obtained from University College
London. The number and age of mice supplied depended
upon local availability. All mice were supplied with wild-
type (WT) littermate controls, and all were genotyped at
source. The microbial status and housing conditions of
colony mice varied between institutions, as detailed in
Table 1.
Histology
Mouse heads were fixed in 10 % neutral buffered formalin,
decalcified, and embedded in paraffin wax. Three-micron
sections were stained with haematoxylin and eosin and
assessed for histological evidence of inflammation of the
middle ear (Cheeseman et al. 2011).
Statistics
We used Fisher’s exact test to compare prevalence of OM
in mutant versus WT littermates.
Results
We examined serial sections of mouse heads from
eight mouse lines [Ts65Dn, Ts1Cje, Ts2Yah, Ts1Rhr,
Dp(16)1Yey, Dp(10)1Yey, Dp(17)1Yey, and Tc1] for
histological evidence of inflammation of the middle ear. A
total of 532 ears were analysed and the results are docu-
mented in Table 2. For one mouse line, Ts65Dn, mice were
gathered from two sources.
Only the Dp(16)1Yey mouse line reliably developed
statistically significant chronic OM (19 ears in 10 of 13
Fig. 1 Map of a murine
synteny to human chromosome
21 and of b trisomic regions in
mouse models of DS used in
this study (showing genes at
chromosome breakpoints). The
syntenic regions to HSA21 are
on MMU16 (76–98 Mb),
MMU17 (31–32 Mb), and
MMU10 (78–76 Mb). The Tc1
mouse carries an incomplete
HSA21 in addition to the
normal mouse genome, whereas
all other models are trisomic for
murine DNA. Known genes are
derived from the Ensembl web
browser
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mice). Histology revealed thickened polypoid mucoperi-
osteum with neutrophil and macrophage infiltration, and an
effusion of variable cellularity (Fig. 2). In this line, disease
was consistently present from the age of 2 months. Some
of the older ([7 months old) WT littermate controls for
this line also developed chronic OM (7 ears in 4 mice), but
OM was not present in any of the younger WT littermates.
OM in other models was not present or it was rarely
present. Given the reported OM in T65Dn mice, we
obtained animals from two different sources. We found no
evidence of OM in either colony. A unilateral small vol-
ume of exudate and inflammatory polyp formation were
noted in one of the Ts65Dn mice from University College
London (Fig. 2). There was also mild unilateral oedema in
the middle-ear mucosa of two Ts65Dn mice from the
Institut Clinique de la Souris, but without a leucocyte
infiltrate (not shown). There was bilateral OM in one
Ts1Cje mouse, with infiltration by macrophages and neu-
trophils (Fig. 2).
Discussion
Chromosomal localisation of OM
In this study we screened the DS mouse library to identify
a critical region for genetic susceptibility to chronic OM.
The Dp(16)1Yey mouse, which is trisomic for the entire
region of MMU16 syntenic to HSA21, was found to
reliably develop chronic OM. Here, OM was early onset
(by 2 months) and with penetrance of 0.73 (19/26 ears). A
few of the WT littermate controls of the Dp(16)1Yey
mice also developed OM, but only when they were older
than 7 months. Chronic OM is common in older labora-
tory mice (Haines et al. 2001), although the reasons are
unclear, and so the pathology in the older WT mice is not
unexpected.
Of note, there was no evidence of OM in the
Dp(17)1Yey and Dp(10)1Yey models, suggesting that only
genes found on MMU16 are responsible for the OM
Table 1 Microbial status of mouse strains
Source Mouse lines FELASA listed microbial agents Housing conditions
Institut Clinique de la
Souris
Ts65Dn, Ts1Cje,
Ts2Yah, Ts1Rhr
Norovirus, Helicobacter spp.,
Pseudomonas aeruginosa,
Entamoeba muris
Individually ventilated cages
with HEPA-filtered air
Roswell Park Dp(10)1Yey, Dp(16)1Yey,
Dp(17)1Yey
Norovirus, Helicobacter spp. Individually ventilated cages
with HEPA-filtered air
University College London Tc1, Ts65Dn Helicobacter hepaticus,
Tritrichomonas
Open cages
FELASA Federation for Laboratory Animal Science Associations
Table 2 Mouse strains used in this study, their source, and presence or absence of OM on histology (denominator is for number of ears)
Mouse line Background
strain
Trisomic segment Source Age range
(months)
OM in
mutant
OM in WT
controls
p value
Dp(17)1Yey B6;129 MMU17 Abcg1-Rrp1b Roswell Park 2–3 0/28 1/32 1
Dp(10)1Yey B6;129 MMU10 Prmt2-Pdxk Roswell Park 2–4 0/28 0/28 1
Dp(16)1Yey B6;129 MMU16 Lipi -Znf295 Roswell Park 2–15 19/26 7/24 0.004
Ts1Cje B6 MMU16 Sod1 Znf295 ICS 2 2/28 0/28 0.491
Ts1RhR B6 MMU16 Cbr1-Mx2 ICS 2 0/36 0/36 1
Ts2Yah B6 MMU16 Stch -App ICS 2 0/34 0/34 1
Ts65Dn C3H;B6 MMU16 Mrpl39-Znf295
& MMU17 Synj2-D17Mit58
ICS 2 2/40a 0/40 0.494
Ts65Dn C3H;B6 MMU16 Mrpl39-Znf295
& MMU17 Synj2-D17Mit58
UCL 11–16 1/12b 0/22 0.353
Tc1 129;B6 HSA21 except Rh46998-D21s11
& Ifngr2-Rh120345
UCL 2–3 0/30 0/26 1
The p values relate to Fisher’s exact test for the difference in OM prevalence in mutants versus wild-type (WT) littermates
UCL University College London, ICS Institut Clinique de la Souris
a Two ears in this cohort of Ts65Dn mice showed mild oedema of the middle-ear mucoperiosteum, but without leucocyte infiltration
b One ear showed a small middle-ear exudate with micropolyp formation
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phenotype. We also found no evidence of OM in the Tc1
mouse, in agreement with recently reported results (Kuhn
et al. 2012). The Tc1 model carries many of the genes
found in trisomy in DS (in the form of mouse and human
chromosomes), but it has been reported to lack many ele-
ments of the DS phenotype. It has been surmised that this
may reflect species differences in genetic regulatory ele-
ments, or it may be the result of genetic mosaicism (Patt-
erson 2009). More recent work also suggests previously
unrecognised gene rearrangements in the Tc1 mouse (E.
Fisher, personal communication).
Our findings strongly implicate a region of MMU16 to
underlie the chronic OM phenotype. Empirically, this
region could be narrowed further by analysis of the
Ts65Dn, Ts1Cje, Ts1Rhr, and Ts2Yah mice, each of
which carry shorter segments trisomic for MMU16
(Fig. 1).
Fig. 2 Histological section through the middle ear of a Dp(16)1Yey
mouse, a Ts65Dn mouse, and a Ts1Cje mouse affected by chronic
OM (H&E stain). There is polypoid hyperplasia of the mucoperios-
teum (m) with an effusion (e) infiltrated by neutrophils and
macrophages. This was present in 19/26 of Dp(16)1Yey mice
examined, 3/52 of Ts65Dn mice, and 1/14 Ts1Cje mice
Table 3 Genes located in the regions Rh46998-D21s11 (region A)
and Ifngr2-Rh123045 (region B)
Gene Relative
transcript
level
Function Candidate
Region A
CXADR ? Coxsackie and adenovirus
receptor, maintains tight
junctions
@
C21ORF ? Unknown
CHODL ? Endocytosis of
glycoproteins and sugar-
bearing pathogens
TMPRSS15 ? Pancreatic enzyme
Region B
IFNGR2 1.37 Receptor subunit for
interferon c
@
TMEM50B 1.43 Brain development
DNAJC28 – May act in protein folding
or as a chaperone
GART 1.46 Purine biosynthesis
SON 1.77 mRNA splicing cofactor
DONSON 1.35 Unknown
CRYZL1 1.40 Unknown
ITSN1 1.42 Coordinates endocytic
membrane traffic
ATP5O 1.40 ATP synthesis
MRPS6 1.28 Mitochondrial protein
synthesis
SLC5A3 0.91 Prevents intracellular
accumulation of myo-
inositol
KCNE2 1.32 Component of voltage-
gated potassium channels
FAM165B 1.39 Unknown
KCNE1 – Component of voltage-
gated potassium channels
RCAN1 0.79 Inhibits calcineurin-
dependent signaling
pathways
CLIC6 – Probable chloride ion
channel
RUNX1 1.31 Functions in
haematopoeisis, interacts
with TGF-b
@
Regions A and B are trisomic in the Dp(16)1Yey mouse (develops
OM), but not in the Tc1 mouse (no OM noted). Relative transcript
levels for region B refer to those in adult lung of Ts65Dn mice (Lyle
et al. 2004); region A is not trisomic in Ts65Dn mice. In the proposed
multigenic model, genes from each of these regions interact to pro-
duce susceptibility to chronic OM. Highlighted ‘‘candidates’’ are
those genes known to be involved in immune signaling
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Localisation of OM within MMU16
We found no OM in Ts1Rhr and Ts2Yah mice, but one
Ts1Cje mouse developed severe bilateral OM. We observed
definitive OM in only one ear of the 52 Ts65Dn ears
screened, although there was mild mucosal oedema in two
other Ts65Dn mouse ears (which may be indicative of early
or mild inflammation). The absence of OM in these four
mouse lines, coupled with the highly penetrant OM observed
in the Dp(16)1Yey mouse, suggests a genetic model for OM
in DS whereby more than one locus is required. Given the
absence of OM in Tc1, this would suggest that the loci are
present in the two chromosome 16 regions not found in Tc1,
i.e., Rh46998-D21s11 and Ifngr2-Rh123045 (Fig. 1b).
Known genes in these two regions and their function are
detailed in Table 3. The first region contains 4 genes, of
which only Cxadr is known to be involved in immune sig-
nalling. The second region contains 17 genes, of which two,
Ifngr2 and Runx1, are known to be involved in immune
signalling. Cxadr and Ifngr2 are usually invoked in response
to viral rather than bacterial infection. Whether these or other
loci in these regions are responsible for persistent middle-ear
inflammation we can only surmise.
In considering this multigenic model, it is important to
examine the differing results reported in this study and those of
Han et al. (2009) regarding the incidence of OM observed in
the Ts65Dn mouse. Han et al. reported a highly penetrant
chronic OM in the Ts65Dn model (in 11/15 mice), with a
variable cellular infiltrate and effusion, accompanied by
audiological evidence of disease onset by the age of 2 months.
The variable penetrance of OM in the Ts65Dn mouse observed
in this and the Han study suggests that development of chronic
OM in DS is not determined solely by a critical genetic
region(s) in trisomy, but also by additional important modifi-
ers of phenotype, possibly genetic, environmental, or both.
Background sequence variation could affect phenotype
penetrance and expressivity. The Ts65Dn mice in our study
were maintained on a C3;B6 background through breeding
with local stock. The Ts65Dn mice reported by Han et al.
were similarly maintained by local breeding on a C3;B6
background. However, even small genomic variations can
play a pivotal role in phenotype penetrance in DS (Anton-
arakis et al. 2004) and thus interlaboratory variation might
affect the OM phenotype. For example, allelic variation in
CRELD1 on HSA3 modifies the risk of cardiac malforma-
tion in children (Maslen et al. 2006). In the mouse, breeding
the Ts1RhR mouse model onto a mixed B6;C3H/129
background, as opposed to pure B6, leads to loss of the
craniofacial phenotype (Keane et al. 2011). However, it is
noteworthy that we obtained T65Dn mice from two separate
sources, and in neither case did we observe OM.
An alternative, and perhaps more likely, explanation is that
an environmental antigen, such as a bacterial pathogen, can
trigger the onset of OM in Ts65Dn mice. Variation in housing
conditions could lead to differences in environmental expo-
sure and so explain variable phenotype penetrance. Han et al.
(2009) reported coagulase-negative Staphylococci, Burk-
holderia cepacia, and Bordetella avium in middle-ear effu-
sions of their Ts65Dn mice, but also Klebsiella oxytoca,
Streptococcus viridans, and B. avium in wild-type controls.
We did not culture bacteria from effusions in this study (only
fixed tissues were used), but because a number of microbes
have been isolated at the source of these animals (Table 2), it
is possible that one or more of these microbes, or other
unidentified microbes, play a pivotal role in disease onset.
In summary, our data suggest a multigenic model for
development of OM in DS mice, whereby loci from two
chromosome 16 regions contribute to the onset of the
disease. Consistent with our proposed model, we failed to
observe definitive OM in the Ts65Dn mouse, which would
carry only one of the required chromosome 16 regions.
However, it may be that environmental insults or other
genetic variation elsewhere in the genome may be suffi-
cient along with the trisomic region present in Ts65Dn
mouse to elicit OM. This would potentially account for the
differences in incidence of OM observed between the work
of Han et al. and the work reported here.
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